Free shipping on all orders over $ 500

D-myo-Inositol 1,4,5-trisphosphate tripotassium

Cat. No. M56449

All AbMole products are for research use only, cannot be used for human consumption.

D-myo-Inositol 1,4,5-trisphosphate tripotassium Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

D-myo-Inositol 1,4,5-trisphosphate tripotassium, a second messenger, elicits Ca2+ mobilization.

Chemical Information
Molecular Weight 534.37
Formula C6H12K3O15P3
CAS Number 141611-11-2
Form Solid
Storage -20°C, dry, sealed
Related Calcium Channel Products
Diltiazem

Diltiazem is an orally active L-type Ca2+ channel blocker. Diltiazem shows antihypertensive and antiarrhythmic effects.

L-Phenylalanine-d8

L-Phenylalanine-d8 is the deuterium labeled L-Phenylalanine. L-Phenylalanine is a α2δ subunit of voltage-dependent Ca+ channels antagonist with a Ki of 980 nM.

CBD3063

CBD3063 is a selective, first-in-class, CRMP2-based peptidomimetic small molecule, which allosterically regulates Cav2.2 to achieve analgesia and pain relief without negative side effect profiles.

TTA-A8 

TTA-A8 is a short-acting T-type calcium channel antagonist with oral activity, exhibiting an IC50 value of 31.3 nM in the FLIPR depolarization assay.

MONIRO-1 

MONIRO-1 is a T-type and N-type calcium channel blocker with IC50 values of 34, 3.3, 1.7 and 7.2 µM against hCav2.2, hCav3.1, hCav3.2 and hCav3.3, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: D-myo-Inositol 1,4,5-trisphosphate tripotassium supplier, Calcium Channel, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.